Marta Molina-Alejandre

2PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 21, 2026
Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

Pageof 1

Frequent Collaborators

2 joint publications

Mariano Provencio Pulla

2 joint publications

Alberto Cruz-Bermúdez

1 joint publications

Belén Sierra-Rodero

1 joint publications

Ángeles Gil-González